First US clinical cases successfully conducted with EndoDrill GI
The cancer diagnostics company BiBBInstruments AB ("BiBB" or the "Company"), the developer of the world's first market-cleared motorized endoscopic core biopsy instrument, announces that the first US clinical procedures with EndoDrill[®] GI have successfully been performed by Dr Antonio Mendoza Ladd and his team at UC Davis Health, Sacramento, California. BiBB received 510(k) clearance from the US FDA for EndoDrill[®] GI in 2023 and clinical marketing activities will continue in the US.BiBB’s CEO Fredrik Lindblad and founder Dr Charles Walther were present when Dr Antonio Mendoza Ladd,